Lannett Overview
- Year Founded
-
1942
- Status
-
Acquired/Merged
- Employees
-
435
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
5
Lannett General Information
Description
Developer of generic medicine intended to serve healthcare markets across the United States. The company develops, manufactures and markets over 100 unique generic prescription product families through its FDA regulated facilities in Pennsylvania, Indiana and New York, thereby delivering affordable quality medications to wholesalers, retailers and patients nationwide.
Contact Information
Website
www.lannett.com(Operating Subsidiary)
Corporate Office
- 1150 Northbrook Drive
- Suite 155
- Trevose, PA 19053
- United States
Corporate Office
- 1150 Northbrook Drive
- Suite 155
- Trevose, PA 19053
- United States
Lannett Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lannett Comparisons
Industry
Financing
Details
Lannett Competitors (38)
One of Lannett’s 38 competitors is Evolus, a Formerly PE-Backed company based in Newport Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evolus | Formerly PE-Backed | Newport Beach, CA | ||||
| Medis ( Pharmaceuticals) | Corporation | Hafnarfjordur, Iceland | ||||
| Camber Pharmaceuticals | Corporation | Piscataway, NJ | ||||
| MS Pharma | Private Equity-Backed | Amman, Jordan | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ |
Lannett Patents
Lannett Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160030723-A1 | Multi-chamber anesthetic delivery system | Inactive | 15-Mar-2013 | ||
| WO-2014145767-A1 | Multi-chamber anesthetic delivery system | Inactive | 15-Mar-2013 | ||
| US-20090148512-A1 | Novel uses of chloramphenicol and analogous thereof | Inactive | 07-Dec-2007 | ||
| WO-2009076243-A2 | Novel uses of chloramphenicol and analogues thereof | Inactive | 07-Dec-2007 | ||
| WO-2009076243-A3 | Novel uses of chloramphenicol and analogues thereof | Inactive | 07-Dec-2007 | A61K9/1623 |
Lannett Signals
Lannett Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lannett Investments & Acquisitions (5)
Lannett’s most recent deal was a Corporate Asset Purchase with Endo International (Portfolio of Generic Products) for . The deal was made on 07-May-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Endo International (Portfolio of Generic Products) | 07-May-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Kremers Urban Pharmaceuticals | 25-Nov-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Silarx Pharmaceuticals | 01-Jun-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Lannett Company (Two Generic Pharmaceutical Products) | 20-Aug-2014 | Merger/Acquisition | Pharmaceuticals | ||
| Cody Laboratories | 10-Apr-2007 | Merger/Acquisition | Pharmaceuticals |
Lannett Exits (1)
Lannett’s most recent exit was on 10-Apr-2007 from Cody Laboratories. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Cody Laboratories | 10-Apr-2007 | Completed |
|
Lannett Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Lannett Company (Liquid Drug Manufacturing Plant And Other Assets in Carmel, New York) | Carmel, NY |
Lannett FAQs
-
When was Lannett founded?
Lannett was founded in 1942.
-
Where is Lannett headquartered?
Lannett is headquartered in Trevose, PA.
-
What is the size of Lannett?
Lannett has 435 total employees.
-
What industry is Lannett in?
Lannett’s primary industry is Pharmaceuticals.
-
Is Lannett a private or public company?
Lannett is a Private company.
-
What is the current valuation of Lannett?
The current valuation of Lannett is .
-
What is Lannett’s current revenue?
The current revenue for Lannett is .
-
How much funding has Lannett raised over time?
Lannett has raised $1.5B.
-
Who are Lannett’s investors?
Athyrium Capital Management and Lannett Seller Holdco have invested in Lannett.
-
Who are Lannett’s competitors?
Evolus, Medis ( Pharmaceuticals), Camber Pharmaceuticals, MS Pharma, and Amneal Pharmaceuticals are some of the 38 competitors of Lannett.
-
When was Lannett acquired?
Lannett was acquired on 29-Jun-2026.
-
Who acquired Lannett?
Lannett was acquired by Aurobindo Pharma USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process